Related Experiment Video
Updated: Feb 27, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Pediatric toxic polycystic thyroid
Insights
Polycystic thyroid disease (PCTD) is a rare condition. This report details the first pediatric case of PCTD with hyperthyroidism, highlighting its occurrence in children.
Area of Science:
- Endocrinology
- Pediatric Endocrinology
- Thyroidology
Background:
- Polycystic thyroid disease (PCTD) is a rare endocrine disorder typically observed in adults with hypothyroidism.
- This study presents the first documented case of diffuse macrocystic degeneration of the thyroid in a pediatric patient.
Observation:
- A 6-year-old presented with a 16-month history of an enlarging polycystic thyroid and hyperthyroidism.
- Autoimmune thyroid disease markers were negative, and there was no family history of thyroid or cystic disease.
- The patient underwent total thyroidectomy and is now euthyroid with hormone replacement therapy.
Findings:
- This case represents the first reported instance of PCTD in a pediatric patient associated with hyperthyroidism.
- The hyperthyroidism was not linked to autoimmune thyroid disease, suggesting alternative underlying mechanisms.
- The patient's condition resolved post-thyroidectomy, with ongoing management for euthyroidism.
Implications:
- Polycystic thyroid degeneration can manifest in children, potentially leading to hyperthyroidism.
- Further research is needed to explore the potential role of somatic activating thyrotropin-receptor gene mutations in pediatric PCTD.
- This case expands the known clinical spectrum of PCTD and its presentation in pediatric populations.
Background:
Polycystic thyroid disease (PCTD) is a rare condition and has been described in adults in the setting of subclinical and clinical hypothyroidism. We present the first known case of a pediatric patient with diffuse macrocystic degeneration of the thyroid.
Clinical Presentation:
A 6-year-old previously healthy patient was evaluated after presenting with a 16-month history of an enlarging polycystic thyroid and hyperthyroidism. Markers of autoimmune thyroid disease including thyroid stimulating immunoglobulin (TSI), thyroid stimulating hormone (TSH) receptor antibody, thyroid peroxidase antibody and thyroglobulin antibody were negative. No family history of benign or malignant thyroid or cystic disease was present. The patient underwent a total thyroidectomy without perioperative complication. She remains euthyroid with thyroid hormone replacement therapy.
Summary:
To our knowledge, this is the first report of PCTD in the pediatric population associated with hyperthyroidism without evidence of autoimmune disease. Somatic activating thyrotropin-receptor gene mutations are known to cause non-autoimmune hyperthyroidism in children, however it is unknown if similar mechanisms are responsible for pediatric PCTD.
Conclusions:
Polycystic thyroid degeneration can occur in children and may result in a hyperthyroid state.
More Related Videos
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children
Drug Toxicity: Dose-Dependent Reactions